Cara Therapeutics | CARA - Employees Total Number

Stock Price
4.18
Daily Change
-0.03 -0.71%
Monthly
41.22%
Yearly
-83.68%
Q2 Forecast
3.07

Cara Therapeutics reported 55 in Employees for its fiscal year ending in December of 2023.





Employees Change Date
Acadia Pharmaceuticals 653 56 Dec/2024
Alterity Therapeutics Limited AUD 12 1 Jun/2022
Assertio Holdings 53 23 Dec/2023
Cara Therapeutics 55 51 Dec/2023
Cassava Sciences 30 1 Dec/2024
Chugai Pharma 7.78K 174 Dec/2024
Cipla 30.31K 2.55K Dec/2025
Clal Biotechnology 3 191 Dec/2023
Compugen USD 74 6 Dec/2024
CSL USD 32.06K 1.67K Dec/2025
Grifols EUR 23.83K 89 Dec/2024
Halozyme Therapeutics 350 23 Dec/2024
J&J 138.1K 6.2K Dec/2024
Neurocrine Biosciences 1.8K 400 Dec/2024
Pacira 790 79 Dec/2024
Pfizer 81K 7K Dec/2024
RedHill Biopharma 113 88 Dec/2022
Supernus Pharmaceuticals 674 22 Dec/2024
Vanda Pharmaceuticals 203 87 Dec/2023